Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Cancer Imaging. 2023 May 19;23(1):46. doi: 10.1186/s40644-023-00548-9.

Authors

Affiliations

¹ Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. therese.sjoholm@surgsci.uu.se.
² Antaros Medical AB, Mölndal, Sweden.
³ Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
⁴ Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

^# Contributed equally.

No abstract available

Publication types

Published Erratum